Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatment

Jacques Tostain; Guorong Li; Anne Gentil-Perret; Marc Gigante

doi:10.1016/j.ejca.2010.07.020

journal article Dec 01, 2010

Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatment

Jacques Tostain Guorong Li

Anne Gentil-Perret Marc Gigante

European Journal of Cancer Vol. 46 No. 18 pp. 3141-3148 · Elsevier BV

View at Publisher Save 10.1016/j.ejca.2010.07.020

Topics

No keywords indexed for this article. Browse by subject →

References

63

[1]

Parkin "Global cancer statistics, 2002" CA Cancer J Clin (2005) 10.3322/canjclin.55.2.74

[2]

Lam "Role of molecular markers in the diagnosis and therapy of renal cell carcinoma" Urology (2005) 10.1016/j.urology.2005.06.112

[3]

Leibovich "Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials" Cancer (2003) 10.1002/cncr.11234

[4]

Kim "Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma" J Urol (2005) 10.1097/01.ju.0000154351.37249.f0

[5]

Oosterwijk "Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney" Int J Cancer (1986) 10.1002/ijc.2910380406

[6]

Zavada "Expression of MaTu-MN protein in human tumor cultures and in clinical specimens" Int J Cancer (1993) 10.1002/ijc.2910540218

[7]

Pastorek "Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment" Oncogene (1994)

[8]

Grabmaier "Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250" Int J Cancer (2000) 10.1002/(sici)1097-0215(20000315)85:6<865::aid-ijc21>3.0.co;2-q

[9]

Zatovicova "Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE/ADAM17" Br J Cancer (2005) 10.1038/sj.bjc.6602861

[10]

Leibovich "Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma" J Clin Oncol (2007) 10.1200/jco.2007.12.1087

[11]

Wykoff "Hypoxia-inducible expression of tumor-associated carbonic anhydrases" Cancer Res (2000)

[12]

McCawley "Matrix metalloproteinases: multifunctional contributors to tumor progression" Mol Med Today (2000) 10.1016/s1357-4310(00)01686-5

[13]

Mandriota "HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron" Cancer Cell (2002) 10.1016/s1535-6108(02)00071-5

[14]

Ivanov "Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel–Lindau transgenes" Proc Natl Acad Sci USA (1998) 10.1073/pnas.95.21.12596

[15]

Patard "Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma" Int J Cancer (2008) 10.1002/ijc.23496

[16]

Ivan "HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing" Science (2001) 10.1126/science.1059817

[17]

Grabmaier "Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma" Oncogene (2004) 10.1038/sj.onc.1207764

[18]

Baldewijns "High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile" Br J Cancer (2007) 10.1038/sj.bjc.6603796

[19]

Li "The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells" Clin Cancer Res (2001)

[20]

Liao "Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney" Cancer Res (1997)

[21]

Li "Antibody-specific detection of CAIX in breast and prostate cancers" Biochem Biophys Res Commun (2009) 10.1016/j.bbrc.2009.06.064

[22]

Bui "Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy" Clin Cancer Res (2003)

[23]

Sandlund "Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma" BJU Int (2007) 10.1111/j.1464-410x.2007.07006.x

[24]

Ivanov "Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer" Am J Pathol (2001) 10.1016/s0002-9440(10)64038-2

[25]

Murakami "MN/CA9 gene expression as a potential biomarker in renal cell carcinoma" BJU Int (1999) 10.1046/j.1464-410x.1999.00007.x

[26]

Zavada "Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients" Br J Cancer (2003) 10.1038/sj.bjc.6601264

[27]

Li G, Feng G, Gentil-Perret A, Genin C, Tostain J. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol 2008;180:510–3 [discussion 13–4]. 10.1016/j.juro.2008.04.024

[28]

Hulick "Blood levels of carbonic anhydrase 9 correlate with clear cell carcinoma activity" Clin Proteom (2009) 10.1007/s12014-008-9012-1

[29]

Zhou "Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials" Urology (2010) 10.1016/j.urology.2009.09.052

[30]

Li "Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma" Clin Cancer Res (2003)

[31]

Nakagawa "Radiation hybrid mapping of the human MN/CA9 locus to chromosome band 9p12–p13" Genomics (1998) 10.1006/geno.1998.5483

[32]

de Martino "CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis" J Urol (2009) 10.1016/j.juro.2009.03.077

[33]

Neuzillet "Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses" J Urol (2004) 10.1097/01.ju.0000120147.51090.2b

[34]

Lechevallier "Fine-needle percutaneous biopsy of renal masses with helical CT guidance" Radiology (2000) 10.1148/radiology.216.2.r00au01506

[35]

Wolf "Evaluation and management of solid and cystic renal masses" J Urol (1998) 10.1016/s0022-5347(01)63529-8

[36]

Li "The use of MN/CA9 gene expression in identifying malignant solid renal tumors" Eur Urol (2006) 10.1016/j.eururo.2005.10.025

[37]

Jensen "Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma" BJU Int (2008) 10.1111/j.1464-410x.2008.07649.x

[38]

Divgi "Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial" Lancet Oncol (2007) 10.1016/s1470-2045(07)70044-x

[39]

Tostain J, Li G. CA9 as a predictive marker of response to therapies of clear cell renal cell carcinoma. Oral presentation. In: Rein AplRslTd, editor. 3rd A.R.Tu.R Symposium 2009, Chantilly (France), 2009.

[40]

Li G, Billal I, Gentil-Perret A, et al. CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Urol Oncol 2010, in press.

[41]

Phuoc "Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma" Oncol Rep (2008)

[42]

Gilbert "Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors" Urology (2006) 10.1016/j.urology.2005.11.034

[43]

Atkins "Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer" Clin Cancer Res (2005) 10.1158/1078-0432.ccr-04-2019

[44]

Brouwers AH, Boerman OC, Oyen WJ. In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer. Clin Cancer Res 2005;11:8886 [author reply 86]. 10.1158/1078-0432.ccr-05-1512

[45]

Cho "Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma" Clin Genitourin Cancer (2007) 10.3816/cgc.2007.n.020

[46]

Signoretti "Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy" BJU Int (2008) 10.1111/j.1464-410x.2008.07646.x

[47]

Wang "Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant" Mol Cancer Ther (2008) 10.1158/1535-7163.mct-08-0603

[48]

Zavada "Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion" Br J Cancer (2000) 10.1054/bjoc.2000.1111

[49]

Svastova "Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin" Exp Cell Res (2003) 10.1016/s0014-4827(03)00351-3

[50]

Franovic "Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17" Cancer Res (2006) 10.1158/0008-5472.can-06-1595

Showing 50 of 63 references

Metrics

112

Citations

63

References

Details

Published: Dec 01, 2010
Vol/Issue: 46(18)
Pages: 3141-3148
License: View

Authors

Cite This Article

Jacques Tostain, Guorong Li, Anne Gentil-Perret, et al. (2010). Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatment. European Journal of Cancer, 46(18), 3141-3148. https://doi.org/10.1016/j.ejca.2010.07.020

Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatment

You May Also Like